169 related articles for article (PubMed ID: 33039498)
1. Repairing the heart: State-of the art delivery strategies for biological therapeutics.
Yang Q; Fang J; Lei Z; Sluijter JPG; Schiffelers R
Adv Drug Deliv Rev; 2020; 160():1-18. PubMed ID: 33039498
[TBL] [Abstract][Full Text] [Related]
2. Delivery of synthetic mRNAs for tissue regeneration.
Steinle H; Weber J; Stoppelkamp S; Große-Berkenbusch K; Golombek S; Weber M; Canak-Ipek T; Trenz SM; Schlensak C; Avci-Adali M
Adv Drug Deliv Rev; 2021 Dec; 179():114007. PubMed ID: 34710530
[TBL] [Abstract][Full Text] [Related]
3. Nanofibers based tissue engineering and drug delivery approaches for myocardial regeneration.
Joshi J; Kothapalli CR
Curr Pharm Des; 2015; 21(15):2006-20. PubMed ID: 25732660
[TBL] [Abstract][Full Text] [Related]
4. Regenerative strategies for the consequences of myocardial infarction: Chronological indication and upcoming visions.
Tajabadi M; Goran Orimi H; Ramzgouyan MR; Nemati A; Deravi N; Beheshtizadeh N; Azami M
Biomed Pharmacother; 2022 Feb; 146():112584. PubMed ID: 34968921
[TBL] [Abstract][Full Text] [Related]
5. mRNA-Based Protein Replacement Therapy for the Heart.
Magadum A; Kaur K; Zangi L
Mol Ther; 2019 Apr; 27(4):785-793. PubMed ID: 30611663
[TBL] [Abstract][Full Text] [Related]
6. The potential for nanotechnology to improve delivery of therapy to the acute ischemic heart.
Evans CW; Iyer KS; Hool LC
Nanomedicine (Lond); 2016 Apr; 11(7):817-32. PubMed ID: 26980180
[TBL] [Abstract][Full Text] [Related]
7. The reduction of infarct size--forty years of research.
Ferreira R
Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
[TBL] [Abstract][Full Text] [Related]
8. Myocardial Delivery of Lipidoid Nanoparticle Carrying modRNA Induces Rapid and Transient Expression.
Turnbull IC; Eltoukhy AA; Fish KM; Nonnenmacher M; Ishikawa K; Chen J; Hajjar RJ; Anderson DG; Costa KD
Mol Ther; 2016 Feb; 24(1):66-75. PubMed ID: 26471463
[TBL] [Abstract][Full Text] [Related]
9. Targeting macrophage subsets for infarct repair.
Ben-Mordechai T; Palevski D; Glucksam-Galnoy Y; Elron-Gross I; Margalit R; Leor J
J Cardiovasc Pharmacol Ther; 2015 Jan; 20(1):36-51. PubMed ID: 24938456
[TBL] [Abstract][Full Text] [Related]
10. Dual delivery of VEGF and ANG-1 in ischemic hearts using an injectable hydrogel.
Rufaihah AJ; Johari NA; Vaibavi SR; Plotkin M; Di Thien DT; Kofidis T; Seliktar D
Acta Biomater; 2017 Jan; 48():58-67. PubMed ID: 27756647
[TBL] [Abstract][Full Text] [Related]
11. Retrograde delivery of stem cells: promising delivery strategy for myocardial regenerative therapy.
Wu K; Mo X; Lu S; Han Z
Clin Transplant; 2011; 25(6):830-3. PubMed ID: 21919964
[TBL] [Abstract][Full Text] [Related]
12. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction.
Qi Q; Lu L; Li H; Yuan Z; Chen G; Lin M; Ruan Z; Ye X; Xiao Z; Zhao Q
Int J Nanomedicine; 2017; 12():4835-4848. PubMed ID: 28744119
[TBL] [Abstract][Full Text] [Related]
13. Angiogenic peptide nanofibers repair cardiac tissue defect after myocardial infarction.
Rufaihah AJ; Yasa IC; Ramanujam VS; Arularasu SC; Kofidis T; Guler MO; Tekinay AB
Acta Biomater; 2017 Aug; 58():102-112. PubMed ID: 28600129
[TBL] [Abstract][Full Text] [Related]
14. Functional polymers of gene delivery for treatment of myocardial infarct.
Won YW; Bull DA; Kim SW
J Control Release; 2014 Dec; 195():110-9. PubMed ID: 25076177
[TBL] [Abstract][Full Text] [Related]
15. Biohybrid cardiac ECM-based hydrogels improve long term cardiac function post myocardial infarction.
Efraim Y; Sarig H; Cohen Anavy N; Sarig U; de Berardinis E; Chaw SY; Krishnamoorthi M; Kalifa J; Bogireddi H; Duc TV; Kofidis T; Baruch L; Boey FYC; Venkatraman SS; Machluf M
Acta Biomater; 2017 Mar; 50():220-233. PubMed ID: 27956366
[TBL] [Abstract][Full Text] [Related]
16. Materials for non-viral intracellular delivery of messenger RNA therapeutics.
Kauffman KJ; Webber MJ; Anderson DG
J Control Release; 2016 Oct; 240():227-234. PubMed ID: 26718856
[TBL] [Abstract][Full Text] [Related]
17. Delivery of Modified mRNA in a Myocardial Infarction Mouse Model.
Kaur K; Sultana N; Hadas Y; Magadum A; Sharkar MTK; Chepurko E; Zangi L
J Vis Exp; 2020 Jun; (160):. PubMed ID: 32597835
[TBL] [Abstract][Full Text] [Related]
18. Heart regeneration after myocardial infarction using synthetic biomaterials.
Pascual-Gil S; Garbayo E; Díaz-Herráez P; Prosper F; Blanco-Prieto MJ
J Control Release; 2015 Apr; 203():23-38. PubMed ID: 25665866
[TBL] [Abstract][Full Text] [Related]
19. A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model.
Nagaoka K; Matoba T; Mao Y; Nakano Y; Ikeda G; Egusa S; Tokutome M; Nagahama R; Nakano K; Sunagawa K; Egashira K
PLoS One; 2015; 10(7):e0132451. PubMed ID: 26167913
[TBL] [Abstract][Full Text] [Related]
20. Adipose-derived stem cells combined with neuregulin-1 delivery systems for heart tissue engineering.
Díaz-Herráez P; Garbayo E; Simón-Yarza T; Formiga FR; Prosper F; Blanco-Prieto MJ
Eur J Pharm Biopharm; 2013 Sep; 85(1):143-50. PubMed ID: 23958325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
